Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection.

NCT00849160 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida